Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Previous antemortem and postmortem tissue fatty acid composition studies have observed significant deficits in the omega-3 fatty acid docosahexaenoic acid (DHA, 22:6n-3) in red blood cell (RBC) and postmortem cortical membranes of patients with unipolar depression. In the present we determined the fatty acid composition of postmortem orbitofrontal cortex (OFC, Brodmann area 10) of patients with bipolar disorder (n=18) and age-matched normal controls (n=19) by gas chromatography. After correction for multiple comparisons, DHA (-24%), arachidonic acid (-14%), and stearic acid (C18:0)(-4.5%) compositions were significantly lower, and cis-vaccenic acid (18:1n-7)(+12.5%) composition significantly higher, in the OFC of bipolar patients relative to normal controls. Based on metabolite:precursor ratios, significant elevations in arachidonic acid, stearic acid, and palmitic acid conversion/metabolism were observed in the OFC of bipolar patients, and were inversely correlated with DHA composition. Deficits in OFC DHA and arachidonic acid composition, and elevations in arachidonic acid metabolism, were numerically (but not significantly) greater in drug-free bipolar patients relative to patients treated with mood-stabilizer or antipsychotic medications. OFC DHA and arachidonic acid deficits were greater in patients plus normal controls with high versus low alcohol abuse severity. These results add to a growing body of evidence implicating omega-3 fatty acid deficiency as well as the OFC in the pathoaetiology of bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human orbitofrontal cortex: linking reward to hedonic experience
Kringelbach, M. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1747 · Cited by 2,180 · cited 1×
“Furthermore, lesion and imaging studies suggest that deficits in OFC function are associated with clinical features that are frequently observed in patients with bipolar disorder, including impulsivity, impairment in reward-based decision making, and substance abuse (Bechara, 2004; Kringelbach, 2005; London et al., 20…”
BackgroundFish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902 · cited 2×
“Fourth, the DHA composition found in the OFC of normal controls may not be representative of a healthy human sample because the majority (79%) died of cardiovascular-related disease which is associated with omega-3 fatty acid insufficiency (Bucher et al., 2002; Daviglus et al., 1997).”
BackgroundMortality of patients with mood disorders: follow-up over 34–38 years
Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881 · cited 1×
“, 2001), two principal causes of mortality in patients with bipolar disorder and unipolar depression (Angst et al., 2002).”
BackgroundOmega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667 · cited 1×
“, 2000), as well as patients with Alzheimer’s disease (Nakada et al., 1990; Soderberg et al., 1991) and peroxisomal disorders (Martinez, 1992).”
BackgroundNeurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.019 · Cited by 426 · cited 1×
“The OFC was selected as the region of interest based on prior postmortem histological studies (Cotter et al., 2005; Rajkowska, 2000; Torrey et al., 2005; Uranova et al., 2001) and neuroimaging studies (Altshuler et al.”
MethodAntioxidant enzyme activities and oxidative stress in affective disorders
Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368 · cited 1×
“The observed deficits in polyunsaturated fatty acid composition may be due to dietary deficiency, impaired biosynthesis from dietary precursors, and/or lipid peroxidation mediated by reactive oxygen species (Kuloglu et al., 2002; Ozcan et al., 2004; Ranjekar et al., 2003).”
BackgroundLipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
Kuloglu, M., Ustundag, B., Atmaca, M., Canatan, H., Tezcan, A. E., & Cinkilinc, N. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.940 · Cited by 321 · cited 1×
“The observed deficits in polyunsaturated fatty acid composition may be due to dietary deficiency, impaired biosynthesis from dietary precursors, and/or lipid peroxidation mediated by reactive oxygen species (Kuloglu et al., 2002; Ozcan et al., 2004; Ranjekar et al., 2003).”
BackgroundKeck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Suppes, T., Frye, M. A., Altshuler, L. L., Kupka, R., Nolen, W. A., Leverich, G. S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.056 · Cited by 234
Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk
Sublette, M. E., Hibbeln, J. R., Galfalvy, H., Oquendo, M. A., & Mann, J. J. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1100 · Cited by 230
Krüger, S., Seminowicz, D., Goldapple, K., Kennedy, S. H., & Mayberg, H. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00691-7 · Cited by 127
Cited by
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Schulzke, S. M., Deshpande, G. C., & Patole, S. K. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.6.583 · Cited by 350
Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids
Zhang, T.-T., Xu, J., Wang, Y.-M., & Xue, C.-H. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.100997 · Cited by 339
Candela, C. G., López, L. M. B., & Kohen, V. L. (2011) · PubMed · doi:10.1590/s0212-16112011000200013 · Cited by 320
Is docosahexaenoic acid synthesis from α-linolenic acid sufficient to supply the adult brain?
Domenichiello, A. F., Kitson, A. P., & Bazinet, R. P. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.04.002 · Cited by 252
Metadata
- Authors
- McNamara, R. K., Jandacek, R., Rider, T., Tso, P., Stanford, K. E., Hahn, C.-G., & Richtand, N. M.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 160
- Issue
- 3
- Pages
- 285-299
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W1999394306
- Cited by
- 147
- References
- 12
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.